Zydus Lifesciences ZYDUSLIFE Sterling Biotech API Acquisition
NiveshIQ
NSE: ZYDUSWELL · Fast Moving Consumer Goods
Zydus Wellness Ltd.
₹483.30▲ ₹20.55 (+4.44%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on ZYDUSWELL. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Zydus Wellness Ltd.
Zydus Wellness Limited operates in the consumer defensive sector, focusing on health and wellness products across Asia, the Middle East, Africa, Oceania, Europe, and North America. Its core revenue drivers include the Glucon-D glucose powder, Sugar Free line of sugar substitutes, and the Complan nutrition drink, which together account for approximately 60% of total sales. Recent developments show a steady 8% YoY revenue growth to ₹4,537 crore, while net income rose to ₹188 crore, reflecting improved margin management. The company has expanded its product portfolio with plant‑based supplements under WeightWorld and mushroom‑based gummies, targeting the growing functional‑food segment. Competitively, Zydus Wellness benefits from strong brand equity and a wide distribution network, positionin
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹2,328 Cr +3.24% | ₹2,709 Cr +16.37% | ₹3,961 Cr +46.22% |
| EBITDA Margin | 13.24% | 14.02% | 12.87% |
| Net Profit | ₹266.90 Cr -14.03% | ₹346.90 Cr +29.97% | ₹197.20 Cr -43.15% |
| EPS | ₹41.94 | ₹54.52 | ₹6.20 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Zydus Lifesciences ZYDUSLIFE: New International Markets Head
Zydus Lifesciences ZYDUSLIFE: New International Markets Head
🔒
+ 3 more stories about Zydus Wellness Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹1, 437 Cr, PAT ₹119 Cr, EPS ₹3.74, EBITDA margin 17.1%. Growth context: revenue YoY +633.2%, PAT YoY -37.4%, revenue QoQ -3.2%, PAT QoQ -26.6%. Street verdict: inline, revenue surprise -2.0%, PAT surprise -4.9%.
Volume growth, premiumisation, distribution reach, same‑store throughput and gross‑margin discipline are the key forward...
FY26 (last completed FY): revenue ₹3, 961 Cr, PAT ₹238 Cr, EBITDA margin 13.0%, EPS ₹6.20. Year-on-year: revenue YoY +46...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Fast Moving Consumer Goods stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for ZYDUSWELL
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track ZYDUSWELL alongside your other holdings
Unlock full ZYDUSWELL research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Zydus Wellness Ltd.?
NiveshIQ detects active intelligence signals for Zydus Wellness Ltd. (ZYDUSWELL) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Zydus Wellness Ltd.?
Zydus Wellness Ltd. operates in the Fast Moving Consumer Goods sector with a market capitalisation of ₹1,649,645.5L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.